investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Role of mTORC2 in GBM - development of a novel therapeutic mTOR kinase inhibitor

Paul S Mischel

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Paul S Mischel

Ludwig Institute for Cancer Research

Heidelberg, Australia | Uppsala, Sweden

Related projects

Perinatal, Familial, and Neighborhood Risk Factors for Childhood Cancer

Brain, nervous system

Pediatric oncology or childhood cancer

Genaro R. Villa

A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep

Brain, nervous system

Frank Furnari

Genotypic Interactions in Brain Cancer Heterogeneity

Brain, nervous system

Melissa L Bondy

International Case Control Study of Malignant Glioma

Brain, nervous system

Dolares Hambardzumyan

Non-Neoplastic Cell Types Dictate Gliomagenesis and Response to Therapy

Brain, nervous system

Yongcheng Song

Chemical Probes Targeting Gliomas with IDH Mutation

Brain, nervous system

Dominique S Michaud

Integrative Modeling of Gene Expression into GWAS of Glioma

Brain, nervous system

Pathology

Raphael E Pollock

SARC Sarcoma SPORE

Brain, nervous system

Pediatric oncology or childhood cancer

Timothy An-Thy Chan

Elucidating and targeting the molecular foundations of IDH mutant glioma

Brain, nervous system